Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner
Yun-zhang Dai, Yong-da Liu, Jie Li, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

The roles and implications of RNA m6A modification in cancer
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 167
Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer
Lianhui Sun, Yuan Zhang, Boyu Yang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 143
Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 55
METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis
Feng Ye, Jin Wu, Fan Zhang
Biochemical and Biophysical Research Communications (2022) Vol. 638, pp. 1-6
Open Access | Times Cited: 40
The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications
Ziying Liu, Lei Gao, Long Cheng, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 487-501
Open Access | Times Cited: 37
The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30
KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo–YAP pathway
Xiaohong Chen, Tiange Lu, Yiqing Cai, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 27
The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity
Jie Li, Xiaogang Liu, Ruiliang Ge, et al.
Nature Immunology (2023) Vol. 24, Iss. 11, pp. 1813-1824
Closed Access | Times Cited: 26
METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway
Hao Yu, Juntao Zhuang, Zijian Zhou, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1471-1491
Open Access | Times Cited: 11
RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives
Shuibin Lin, Ming Kuang
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 4, pp. 267-281
Closed Access | Times Cited: 10
Methylated lncRNAs suppress apoptosis of gastric cancer stem cells via the lncRNA–miRNA/protein axis
Ci Yuan, Yuan Zhang, Xiaobo Zhang
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 9
Emerging role of RNA modification and long noncoding RNA interaction in cancer
Liqiong Yang, Lu Tang, Qi Min, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 6, pp. 816-830
Open Access | Times Cited: 8
The promoting effect of the POU3F2/METTL16/PFKM cascade on glycolysis and tumorigenesis of hepatocellular carcinoma
Ming Chen, Yuan Yang, Guangsheng Hu, et al.
Annals of Hepatology (2025), pp. 101776-101776
Open Access | Times Cited: 1
RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Non-histone lactylation: unveiling its functional significance
Peng Shi, Yongjie Ma, Shangzhe Zhang
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access | Times Cited: 1
Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance
Mehrdad Hashemi, Eisa Sabouni, Parham Rahmanian, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 20
Multifaceted role of NF-κB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, et al.
Environmental Research (2023) Vol. 228, pp. 115767-115767
Closed Access | Times Cited: 16
METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma
Jialin Wang, Mengxi Xiu, Jin Wang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Crosstalk between m6A modification and non-coding RNAs in HCC
Zitong Qiu, Xingxing Yuan, Xinyue Wang, et al.
Cellular Signalling (2024) Vol. 117, pp. 111076-111076
Closed Access | Times Cited: 6
N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment
Lan Yang, Siyuan Tian, Xiaohong Zheng, et al.
Journal of Gastroenterology (2023) Vol. 58, Iss. 8, pp. 718-733
Closed Access | Times Cited: 15
N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2′-O methylation
Yiqing Zhu, Bang Xiao, Meng Liu, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 15
Novel insights into mutual regulation between N6-methyladenosine modification and LncRNAs in tumors
Nan Zhang, Yifei Sun, Zongqin Mei, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
m6A methyltransferase METTL16 mediates immune evasion of colorectal cancer cells via epigenetically regulating PD-L1 expression
Ailei Wang, Yingjie Sun, Xince Wang, et al.
Aging (2023) Vol. 15, Iss. 16, pp. 8444-8457
Open Access | Times Cited: 14
N6‐methyladenosine‐modified FAM111A‐DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111A
Jian Pu, Zuoming Xu, Youguan Huang, et al.
Cancer Science (2023) Vol. 114, Iss. 9, pp. 3649-3665
Open Access | Times Cited: 13
Epigenetic regulation in female reproduction: the impact of m6A on maternal-fetal health
Peipei Li, Yumeng Lin, Hongyun Ma, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top